ReviewCancer chemotherapy and pharmacology2026
Targeting the GSK-3β/mTOR axis to overcome chemoresistance in gestational choriocarcinoma: molecular mechanisms and therapeutic opportunities.
Marwan Al-Hajeili et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it